---
title: >-
  Assessing The Value Of Linking Abstracted Medical Record Data With
  Administrative Claims Data To Study Patients With High-Risk Non-Muscle
  Invasive Bladder Cancer In The United States.
description: >-
  Explore this publication on real-world evidence: Assessing The Value Of
  Linking Abstracted Medical Record Data With Administrative Claims Data To
  Study…
date: '2024-01-01'
category: Publications
tags:
  - ISPOR Annual Conference
  - Poster Presentation
  - R&D
  - Care
  - Methods/Pharmacoepi
  - Oncology
  - Pharma Partner
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/ispor-annual-conference/assessing-the-value-of-linking-abstracted-medical-record/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: assessing-the-value-of-linking-abstracted-medical-record
id: OpIvpNi4PlCK1XEFzeOWf
contentType: article
---

## Challenge

Studying high-risk NMIBC in real-world settings is methodologically challenging because claims data lack the structured pathology and staging information needed to identify HR NMIBC diagnoses, while medical records alone cannot capture long-term outcomes.

## Solution

Target RWE and Merck researchers developed and evaluated a data linkage approach connecting abstracted medical record data with Komodo Healthcare Map administrative claims to study HR NMIBC patients.

## Impact

Demonstrating that linked medical record and claims data can characterize HR NMIBC treatment patterns and long-term outcomes provides Merck with a validated data infrastructure for real-world evidence generation for its bladder cancer portfolio.